Dr.Reddys Laboratories | DRRD - Selling And Administration Expenses

Stock Price
1,292.30
Daily Change
-26.70 -2.02%
Monthly
1.80%
Yearly
12.31%
Q1 Forecast
1,267.10

Dr.Reddys Laboratories reported INR26.92B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 5.62B 252M Jun/2025
Bharat Petroleum INR 8.66B 88.2M Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
UPL INR 15.8B 660M Sep/2025